Showing results (81-90 of 164) with videos related to
Sort By:
Pageof 17
Journal of Clinical Psychopharmacology|October 1, 1987
The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophreniaJ D Cohen, T Van Putten, S Marder, et al.Archives of General Psychiatry|February 1, 1981
Chlorpromazine levels and the outcome of treatment in schizophrenic patientsP R May, T Van Putten, D J Jenden, et al.Clinical Pharmacology and Therapeutics|October 6, 2016
Repurposing Drugs for Cognition in SchizophreniaY S Yang, S R Marder, M F GreenScience (New York, N.Y.)|April 5, 1991
Approaches for optimizing the first electronic hyperpolarizability of conjugated organic moleculesS R Marder, D N Beratan, L T ChengThe Journal of Nervous and Mental Disease|November 1, 1983
Span of apprehension performance, neuropsychological functioning, and indices of psychosis-pronenessR F Asarnow, K H Nuechterlein, S R MarderPhysical Chemistry Chemical Physics : PCCP|January 16, 2014
Adsorption studies of a phosphonic acid on ITO: film coverage, purity, and induced electronic structure changesS A Paniagua, E L Li, S R MarderScience (New York, N.Y.)|August 11, 1989
Synthesis of organic salts with large second-order optical nonlinearitiesS R Marder, J W Perry, W P SchaeferPharmacopsychiatry|July 10, 1998
Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detectionM Aravagiri, S R Marder, D Wirshing, et al.Psychiatry Research|December 1, 1987
L-5-hydroxytryptophan attenuates positive psychotic symptoms induced by D-amphetamineM R Irwin, S R Marder, F Fuentenebro, et al.Therapeutic Drug Monitoring|June 1, 1997
Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detectionM Aravagiri, D Ames, W C Wirshing, et al.Pageof 17